Martin Brenner - 11 Nov 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role: Chief Scientific Officer
Signature: /s/ Martin Brenner
Issuer symbol: IBIO
Transactions as of: 11 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Nov 2022, 07:34:00 UTC
Previous filing: 31 Aug 2022
Next filing: 24 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBIO	Common Stock	Award	$0	+95,348		$0.000000	95,348	11 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 95,348 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 95,348 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 95,348 RSUs vest the earlier of: (i) July 1, 2023, or (ii) the successful achievement of the Corporation's 2023 objectives, as defined by the Board of Directors.

Content

Consists of 95,348 shares of iBio, Inc. (the "Company") common stock, $0.001 par value per share (the "Common Stock") represented by 95,348 restricted stock units ("RSUs") granted under the Company's 2020 Omnibus Equity Incentive Plan, (the "2020 Plan"). Each RSU represents a contingent right to receive one share of Common Stock. The 95,348 RSUs vest the earlier of: (i) July 1, 2023, or (ii) the successful achievement of the Corporation's 2023 objectives, as defined by the Board of Directors.